Impact of indomethacin combined with pancreatic duct stent placement on high-risk populations of pancreatitis after endoscopic retrograde cholangiopancreatography

doi:10.4240/wjgs.v18.i3.115383

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 3

This Article

(28)

(30)

(0)

(14)

(424)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Surg. Mar 27, 2026; 18(3): 115383
Published online Mar 27, 2026. doi: 10.4240/wjgs.v18.i3.115383

Table 2 Comparison of related inflammatory factors before and after surgery among the three groups, mean ± SD

Groups	IL-6 (pg/mL)		IL-10 (pg/mL)		CRP (mg/L)
Groups	Before surgery	24 hours after surgery	Before surgery	24 hours after surgery	Before surgery	24 hours after surgery
Indomethacin group	12.3 ± 1.2	58.7 ± 5.3	8.5 ± 0.9	32.1 ± 3.2	5.2 ± 0.6	28.4 ± 2.8
Stent group	11.8 ± 1.1	62.4 ± 5.8	8.2 ± 0.8	35.6 ± 3.5	5.0 ± 0.5	31.7 ± 3.1
Combined group	12.1 ± 1.3	42.6 ± 4.1	8.4 ± 0.7	24.3 ± 2.4	5.1 ± 0.6	19.8 ± 1.9
F-score	0.82	35.67	0.91	28.43	0.75	30.15
P value	0.35	0.008	0.28	0.013	0.41	0.021

IL: Interleukin; CRP: C-reactive protein.

Full Size Table

Citation: Xu K, Zhou DH, Liu JS, Feng J. Impact of indomethacin combined with pancreatic duct stent placement on high-risk populations of pancreatitis after endoscopic retrograde cholangiopancreatography. World J Gastrointest Surg 2026; 18(3): 115383
URL: https://www.wjgnet.com/1948-9366/full/v18/i3/115383.htm
DOI: https://dx.doi.org/10.4240/wjgs.v18.i3.115383

Xu K, Zhou DH, Liu JS, Feng J. Impact of indomethacin combined with pancreatic duct stent placement on high-risk populations of pancreatitis after endoscopic retrograde cholangiopancreatography. World J Gastrointest Surg 2026; 18(3): 115383 [DOI: 10.4240/wjgs.v18.i3.115383]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.